Literature DB >> 30833336

The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence.

Liliane Mukaremera1, Tami R McDonald2, Judith N Nielsen3, Christopher J Molenaar1, Andrew Akampurira4, Charlotte Schutz5, Kabanda Taseera6, Conrad Muzoora6, Graeme Meintjes5, David B Meya4, David R Boulware7, Kirsten Nielsen8.   

Abstract

Cryptococcal meningitis (CM) causes high rates of HIV-related mortality, yet the Cryptococcus factors influencing patient outcome are not well understood. Pathogen-specific traits, such as the strain genotype and degree of antigen shedding, are associated with the clinical outcome, but the underlying biology remains elusive. In this study, we examined factors determining disease outcome in HIV-infected cryptococcal meningitis patients infected with Cryptococcus neoformans strains with the same multilocus sequence type (MLST). Both patient mortality and survival were observed during infections with the same sequence type. Disease outcome was not associated with the patient CD4 count. Patient mortality was associated with higher cryptococcal antigen levels, the cerebrospinal fluid (CSF) fungal burden by quantitative culture, and low CSF fungal clearance. The virulence of a subset of clinical strains with the same sequence type was analyzed using a mouse inhalation model of cryptococcosis. We showed a strong association between human and mouse mortality rates, demonstrating that the mouse inhalation model recapitulates human infection. Similar to human infection, the ability to multiply in vivo, demonstrated by a high fungal burden in lung and brain tissues, was associated with mouse mortality. Mouse survival time was not associated with single C. neoformans virulence factors in vitro or in vivo; rather, a trend in survival time correlated with a suite of traits. These observations show that MLST-derived genotype similarities between C. neoformans strains do not necessarily translate into similar virulence either in the mouse model or in human patients. In addition, our results show that in vitro assays do not fully reproduce in vivo conditions that influence C. neoformans virulence.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Cryptococcuszzm321990; Cryptococcus neoformanszzm321990; cryptococcosis; human; meningitis; model; mouse; pathogenesis; sequence type; virulence

Mesh:

Year:  2019        PMID: 30833336      PMCID: PMC6479045          DOI: 10.1128/IAI.00046-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection.

Authors:  J Rivera; M Feldmesser; M Cammer; A Casadevall
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 2.  Cryptococcosis diagnosis and treatment: What do we know now.

Authors:  John R Perfect; Tihana Bicanic
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

Review 3.  Virulence factors of Cryptococcus neoformans.

Authors:  T R Kozel
Journal:  Trends Microbiol       Date:  1995-08       Impact factor: 17.079

4.  Early mycological treatment failure in AIDS-associated cryptococcal meningitis.

Authors:  P A Robinson; M Bauer; M A Leal; S G Evans; P D Holtom; D A Diamond; J M Leedom; R A Larsen
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

5.  Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors.

Authors:  Cornelius J Clancy; M Hong Nguyen; Ruth Alandoerffer; Shaoji Cheng; Kenneth Iczkowski; Malcolm Richardson; John R Graybill
Journal:  Microbiology       Date:  2006-08       Impact factor: 2.777

6.  Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.

Authors:  Kyle D Smith; Beatrice Achan; Kathy Huppler Hullsiek; Tami R McDonald; Laura H Okagaki; Ali A Alhadab; Andrew Akampurira; Joshua R Rhein; David B Meya; David R Boulware; Kirsten Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

7.  Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.

Authors:  Andrew Kambugu; David B Meya; Joshua Rhein; Meagan O'Brien; Edward N Janoff; Allan R Ronald; Moses R Kamya; Harriet Mayanja-Kizza; Merle A Sande; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

8.  Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice.

Authors:  Anastasia P Litvintseva; Thomas G Mitchell
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

9.  Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.

Authors:  Edward Sionov; Yun C Chang; H Martin Garraffo; Kyung J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

10.  Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.

Authors:  Joseph N Jarvis; Tihana Bicanic; Angela Loyse; Daniel Namarika; Arthur Jackson; Jesse C Nussbaum; Nicky Longley; Conrad Muzoora; Jacob Phulusa; Kabanda Taseera; Creto Kanyembe; Douglas Wilson; Mina C Hosseinipour; Annemarie E Brouwer; Direk Limmathurotsakul; Nicholas White; Charles van der Horst; Robin Wood; Graeme Meintjes; John Bradley; Shabbar Jaffar; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2013-12-06       Impact factor: 9.079

View more
  19 in total

1.  Human IgM Inhibits the Formation of Titan-Like Cells in Cryptococcus neoformans.

Authors:  Nuria Trevijano-Contador; Kaila M Pianalto; Connie B Nichols; Oscar Zaragoza; J Andrew Alspaugh; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Lineages Derived from Cryptococcus neoformans Type Strain H99 Support a Link between the Capacity to Be Pleomorphic and Virulence.

Authors:  Kenya E Fernandes; James A Fraser; Dee A Carter
Journal:  mBio       Date:  2022-03-08       Impact factor: 7.786

3.  Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination.

Authors:  Carolina Coelho; Emma Camacho; Antonio Salas; Alexandre Alanio; Arturo Casadevall
Journal:  mSphere       Date:  2019-08-07       Impact factor: 4.389

4.  Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection.

Authors:  Aleeza C Gerstein; Katrina M Jackson; Tami R McDonald; Yina Wang; Benjamin D Lueck; Sara Bohjanen; Kyle D Smith; Andrew Akampurira; David B Meya; Chaoyang Xue; David R Boulware; Kirsten Nielsen
Journal:  mBio       Date:  2019-07-16       Impact factor: 7.867

5.  Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.

Authors:  Damian J Krysan; Bing Zhai; Sarah R Beattie; Kara M Misel; Melanie Wellington; Xiaorong Lin
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

Review 6.  Animal Models of Cryptococcus neoformans in Identifying Immune Parameters Associated With Primary Infection and Reactivation of Latent Infection.

Authors:  Tyler G Normile; Arielle M Bryan; Maurizio Del Poeta
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

Review 7.  Cryptococcal Virulence in Humans: Learning From Translational Studies With Clinical Isolates.

Authors:  Herdson Renney de Sousa; Stefânia de Frazão; Getúlio Pereira de Oliveira Júnior; Patrícia Albuquerque; André Moraes Nicola
Journal:  Front Cell Infect Microbiol       Date:  2021-04-21       Impact factor: 5.293

8.  Landscape of gene expression variation of natural isolates of Cryptococcus neoformans in response to biologically relevant stresses.

Authors:  Chen-Hsin Yu; Yuan Chen; Christopher A Desjardins; Jennifer L Tenor; Dena L Toffaletti; Charles Giamberardino; Anastasia Litvintseva; John R Perfect; Christina A Cuomo
Journal:  Microb Genom       Date:  2020-01

Review 9.  The interplay of phenotype and genotype in Cryptococcus neoformans disease.

Authors:  Sophie Altamirano; Katrina M Jackson; Kirsten Nielsen
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

Review 10.  Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review.

Authors:  Marhiah C Montoya; Paul M Magwene; John R Perfect
Journal:  J Fungi (Basel)       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.